On Jan. 11, 2021, Moderna announced that it was expanding its pipeline of innovative vaccines with three new…
On Jan. 11, 2021, AXIM Biotechnologies announced that it had released a preprint of its manuscript describing the…
On Jan. 10, 2021, Humanigen announced that they were partnering to make lenzilumab available to hospitalized and hypoxic…
On Jan. 8, 2021, the COVID-19 vaccine developed by Moderna has today been given regulatory approval for supply…
On Jan. 8, 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) announced it had accepted the recommendation…
On Jan. 8, 2021, Pfizer and BioNTech announced results from an in vitro study conducted by Pfizer and…
On Jan. 8, 2021, BioNTech announced that it was in talks with the European Commission (EC) about an…
On Jan. 7, 2021, Oragenics announced entering into a material transfer agreement with Adjuvance Technologies for use of…
On Jan. 7, 2021, Novavax announced that it had executed an Advance Purchase Agreement with the Commonwealth of…
On Jan. 7, 2021, LabCorp announced that it had been awarded a contract from the Centers for Disease…
On Jan. 6, 2021, the U.S. Department of Health and Human Services (HHS) announced the Centers for Disease…
On Jan. 6, 2021, the La Jolla Institute for Immunology announced data that suggest nearly all COVID-19 survivors…
On Jan. 6, 2021, Moderna announced that the European Commission had granted a conditional marketing authorization for COVID-19…
On Jan. 6, 2021, Bayer announced it had signed a collaboration and services agreement with CureVac, a biopharmaceutical…
On Jan. 5, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) announed that a phase 2/3…
On Jan. 5, 2021, Illumina and Helix announced a collaboration to augment national surveillance infrastructure in the U.S….
On Jan. 5, 2021, AIM ImmunoTech announced that the active AMP-511 Expanded Access Program (EAP) had dosed its…
On Jan. 4, 2021, the FDA announced that the two different mRNA vaccines were shown remarkable effectiveness of…
On Jan. 4, 2021, a research partnership between scientists at Scripps Research and UC San Diego found the…
On Jan. 4, 2021, Moderna announced a supply update for the Moderna COVID-19 Vaccine, increasing its base-case global…
On Jan. 4, 2021, Moderna announced that Israel’s Ministry of Health (MOH) had given authorization to import the…
On Jan. 4, 2021, Inovio Pharmaceuticals and Advaccine Biopharmaceuticals announced that they had entered into a collaboration and…
On Dec. 31, 2020, the World Health Organization (WHO) listed the Comirnaty COVID-19 mRNA vaccine for emergency use,…
On Dec. 31, 2020, Moderna confirmed it had entered into a supply agreement with the government of the…
On Dec. 31, 2020, CytoDyn announced a research manuscript submitted by Nicholas J. Agresti, M.D. had been accepted…
On Dec. 30, 2020, Moderna announced that they had reached an agreement to support formulation and fill-finish a…
On Dec. 30, 2020, Bausch Health announced that the Office for Registration of Medicinal Products, Medical Devices and…
On Dec. 30, 2020, the NIH researchers announced that an in-depth study of how COVID-19 affects a patientï¾’s…
On Dec. 30, 2020, the National Institutes of Health (NIH) announced that the investigational vaccine known as mRNA-1273…
On Dec. 30, 2020, Medigen Vaccine Biologics announced that it had obtained TFDA Phase 2 IND approval of…